San Francisco Bay Area biotech stories.
Monday, August 27, 2012
FDA extends use of NovaBay wound cleaner, new spray pump
A wound-cleaning system from
NovaBay Pharmaceuticals Inc.
was cleared for wider use Monday by the Food and Drug Administration
. The NeutroPhase skin and would cleanser and a related spray pump from Emeryville-based NovaBay (AMEX: NBY) were cleared through the FDA's 510(k) process for medical devices. NeutroPhase consists of hypochlorous acid, a common disinfectant, in normal saline.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)